Apeloa Pharmaceutical Co.,Ltd (SHE:000739)
China
· Delayed Price · Currency is CNY 17.91
+0.32 (1.82%)
Mar 10, 2026, 12:34 PM CST
SHE:000739 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 20,201 | 18,836 | 17,996 | 25,222 | 41,354 | 27,436 | Upgrade
|
| Market Cap Growth | 12.43% | 4.67% | -28.65% | -39.01% | 50.73% | 79.49% | Upgrade
|
| Enterprise Value | 17,901 | 15,909 | 15,202 | 22,812 | 39,127 | 25,105 | Upgrade
|
| Last Close Price | 17.59 | 15.52 | 14.39 | 19.83 | 31.93 | 21.02 | Upgrade
|
| PE Ratio | 23.59 | 18.27 | 17.05 | 25.50 | 43.28 | 33.59 | Upgrade
|
| Forward PE | 14.07 | 23.03 | 23.03 | 23.03 | 23.03 | 23.03 | Upgrade
|
| PS Ratio | 1.92 | 1.57 | 1.57 | 2.39 | 4.62 | 3.48 | Upgrade
|
| PB Ratio | 3.11 | 2.79 | 2.89 | 4.57 | 8.17 | 6.25 | Upgrade
|
| P/TBV Ratio | 3.28 | 2.94 | 3.06 | 4.89 | 8.81 | 6.81 | Upgrade
|
| P/FCF Ratio | 39.79 | 25.18 | 44.89 | 30.87 | - | 36.96 | Upgrade
|
| P/OCF Ratio | 24.72 | 15.58 | 17.45 | 19.02 | 67.60 | 25.90 | Upgrade
|
| EV/Sales Ratio | 1.71 | 1.32 | 1.33 | 2.16 | 4.38 | 3.19 | Upgrade
|
| EV/EBITDA Ratio | 13.32 | 10.10 | 9.32 | 17.60 | 29.69 | 21.50 | Upgrade
|
| EV/EBIT Ratio | 23.63 | 15.72 | 14.11 | 25.16 | 40.78 | 30.48 | Upgrade
|
| EV/FCF Ratio | 35.26 | 21.27 | 37.92 | 27.92 | - | 33.82 | Upgrade
|
| Debt / Equity Ratio | 0.19 | 0.14 | 0.15 | 0.15 | 0.09 | 0.08 | Upgrade
|
| Debt / EBITDA Ratio | 0.91 | 0.57 | 0.56 | 0.65 | 0.36 | 0.28 | Upgrade
|
| Debt / FCF Ratio | 2.41 | 1.22 | 2.30 | 1.02 | - | 0.45 | Upgrade
|
| Net Debt / Equity Ratio | -0.35 | -0.41 | -0.43 | -0.49 | -0.42 | -0.45 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.73 | -1.75 | -1.63 | -2.10 | -1.63 | -1.70 | Upgrade
|
| Net Debt / FCF Ratio | -4.55 | -3.68 | -6.64 | -3.32 | 23.85 | -2.67 | Upgrade
|
| Asset Turnover | 0.83 | 0.94 | 0.93 | 1.00 | 1.08 | 1.12 | Upgrade
|
| Inventory Turnover | 4.65 | 4.68 | 4.44 | 5.29 | 5.63 | 5.48 | Upgrade
|
| Quick Ratio | 1.07 | 1.05 | 0.94 | 0.95 | 1.13 | 1.25 | Upgrade
|
| Current Ratio | 1.43 | 1.43 | 1.33 | 1.29 | 1.53 | 1.70 | Upgrade
|
| Return on Equity (ROE) | 13.17% | 15.88% | 17.96% | 18.70% | 20.22% | 20.02% | Upgrade
|
| Return on Assets (ROA) | 3.72% | 4.96% | 5.44% | 5.38% | 7.25% | 7.34% | Upgrade
|
| Return on Invested Capital (ROIC) | 14.92% | 22.91% | 29.63% | 31.03% | 30.94% | 29.60% | Upgrade
|
| Return on Capital Employed (ROCE) | 11.20% | 14.50% | 16.70% | 15.10% | 18.20% | 17.90% | Upgrade
|
| Earnings Yield | 4.27% | 5.47% | 5.86% | 3.92% | 2.31% | 2.98% | Upgrade
|
| FCF Yield | 2.51% | 3.97% | 2.23% | 3.24% | -0.22% | 2.71% | Upgrade
|
| Dividend Yield | 1.97% | 2.30% | 2.20% | 1.50% | 0.89% | 1.16% | Upgrade
|
| Payout Ratio | 97.09% | 38.95% | 36.29% | 36.68% | 31.60% | 24.65% | Upgrade
|
| Buyback Yield / Dilution | 0.87% | 0.52% | 0.40% | 0.38% | 0.00% | -0.01% | Upgrade
|
| Total Shareholder Return | 2.84% | 2.81% | 2.61% | 1.87% | 0.89% | 1.15% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.